Alessandro Moretta
Alessandro Moretta
School of Medicine, University of Genova, Italy
Email verificata su unige.it
Titolo
Citata da
Citata da
Anno
Innate or adaptive immunity? The example of natural killer cells
E Vivier, DH Raulet, A Moretta, MA Caligiuri, L Zitvogel, LL Lanier, ...
science 331 (6013), 44-49, 2011
23782011
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
A Moretta, C Bottino, M Vitale, D Pende, C Cantoni, MC Mingari, ...
Annual review of immunology 19 (1), 197-223, 2001
19742001
Receptors for HLA class-I molecules in human natural killer cells
A Moretta, C Bottino, M Vitale, D Pende, R Biassoni, MC Mingari, ...
Annual review of immunology 14 (1), 619-648, 1996
9581996
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
D Pende, S Parolini, A Pessino, S Sivori, R Augugliaro, L Morelli, ...
The Journal of experimental medicine 190 (10), 1505-1516, 1999
9001999
Human bone marrow–derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms
ME Bernardo, N Zaffaroni, F Novara, AM Cometa, MA Avanzini, A Moretta, ...
Cancer research 67 (19), 9142-9149, 2007
8692007
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule
C Bottino, R Castriconi, D Pende, P Rivera, M Nanni, B Carnemolla, ...
The Journal of experimental medicine 198 (4), 557-567, 2003
8612003
NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non–major histocompatibility complex–restricted tumor cell lysis
M Vitale, C Bottino, S Sivori, L Sanseverino, R Castriconi, E Marcenaro, ...
The Journal of experimental medicine 187 (12), 2065-2072, 1998
8501998
Natural killer cells and dendritic cells: rendezvous in abused tissues
A Moretta
Nature Reviews Immunology 2 (12), 957-965, 2002
7862002
Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
H Ikeda, B Lethé, F Lehmann, N Van Baren, JF Baurain, C De Smet, ...
Immunity 6 (2), 199-208, 1997
7771997
Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a …
R Maccario, M Podestà, A Moretta, A Cometa, P Comoli, D Montagna, ...
Haematologica 90 (4), 516-525, 2005
7642005
Guidelines for the use of flow cytometry and cell sorting in immunological studies
A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ...
European journal of immunology 49 (10), 1457-1973, 2019
7172019
Unravelling natural killer cell function: triggering and inhibitory human NK receptors
L Moretta, A Moretta
The EMBO journal 23 (2), 255-259, 2004
7172004
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra-and intracellular domains
N Wagtmann, R Biassoni, C Cantoni, S Verdiani, MS Malnati, M Vitale, ...
Immunity 2 (5), 439-449, 1995
6901995
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
CS Brandt, M Baratin, EC Yi, J Kennedy, Z Gao, B Fox, B Haldeman, ...
Journal of Experimental Medicine 206 (7), 1495-1503, 2009
6562009
Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity
A Pessino, S Sivori, C Bottino, A Malaspina, L Morelli, L Moretta, ...
The Journal of experimental medicine 188 (5), 953-960, 1998
6541998
The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic
G Ferlazzo, D Thomas, SL Lin, K Goodman, B Morandi, WA Muller, ...
The Journal of Immunology 172 (3), 1455-1462, 2004
6362004
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to …
D Pende, P Rivera, S Marcenaro, CC Chang, R Biassoni, R Conte, ...
Cancer research 62 (21), 6178-6186, 2002
6352002
Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells
R Castriconi, C Cantoni, M Della Chiesa, M Vitale, E Marcenaro, R Conte, ...
Proceedings of the National Academy of Sciences 100 (7), 4120-4125, 2003
6212003
p46, a novel natural killer cell–specific surface molecule that mediates cell activation
S Sivori, M Vitale, L Morelli, L Sanseverino, R Augugliaro, C Bottino, ...
The Journal of experimental medicine 186 (7), 1129-1136, 1997
6041997
P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of …
A Moretta, M Vitale, C Bottino, AM Orengo, L Morelli, R Augugliaro, ...
The Journal of experimental medicine 178 (2), 597-604, 1993
5891993
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20